Chemical Exposures: Low Levels and High Stakes, 2nd edition 1998
by Nicholas Ashford and Claudia Miller
Click for PDF version
Latest Publications
2025
Palmer RF, Kattari D, Verduzco-Gutierrez M. Effects of the COVID-19 pandemic on individuals with chemical intolerance. Fam Med Community Health. 2025 Apr 24;13(2):e003081. doi: 10.1136/fmch-2024-003081. PMID: 40280594; PMCID: PMC12035467.
2024
Rincón R, Perales R, Palmer RF, et al. Environmental house calls can reduce symptoms of chemical intolerance: a demonstration of personalized exposure medicine. Prim Health Care Res Dev. 2024;25:e53. Published 2024 Oct 22. doi:10.1017/S146342362400046X
Palmer RF, Kattari D, Rincon R, Miller CS. Assessing Chemical Intolerance in Parents Predicts the Risk of Autism and ADHD in Their Children. Journal of Xenobiotics. (2024); 14(1):350-367.
Ravi T, Johnson-Esparza Y, Hernandez J, Andry N, Ali F, Del Pilar Montanez Villacampa M, Rincon R, Perales R, & Palmer RF. Clinical assessment and patient education of chemical intolerance. International Journal of Community Medicine and Public Health. (2024).
Johnson-Esparza, Y., Wood, R., Cruz, I. et al. Diabetes quality of life, Chemical Intolerance, and generational status in a Latino sample: an RRNeT study. J Diabetes Metab Disord (2024).
2023
Palmer RF, Dempsey TT, Afrin, LB. Chemical Intolerance and Mast Cell Activation: A Suspicious Synchronicity. Journal of Xenobiotics (2023), 13(4), 704–718.
Palmer RF, Almeida M, Perales RB, Rincon R. A genome-wide SNP investigation of chemical intolerance, Environmental Advances, 12,(2023), 2666-7657
Miller CS, Palmer RF, Kattari D, Masri S, Ashford NA, Rincon R, Perales RB, Grimes C. and Sundblad DR, What Initiates Chemical Intolerance? Findings from a Large Population-Based Survey of US Adults. Environmental Sciences Europe (2023), 35:65.
2022
Palmer RF, Rincon R., Perales RB, Walker TT, Jaén CR, Miller CS. The Brief Environmental Exposure and Sensitivity Inventory (BREESI): an international validation study. Environ Sci Eur 34, 32 (2022).
Perales RB, Palmer RF, Rincon R, Viramontes JN, Walker TT, Jaén CR, Miller CS. Does improving indoor air quality lessen symptoms associated with chemical intolerance? Prim Health Care Res Dev. (2022) Jan 12;23:e3.
2021
Palmer RF, Walker T, Kattari D, Rincon R, Perales RB, Jaén CR, Grimes C, Sundblad DR, Miller CS. Validation of a Brief Screening Instrument for Chemical Intolerance in a Large U.S. National Sample. Int J Environ Res Public Health. (2021) Aug 18;18(16):8714.
Miller CS, Palmer RF, Dempsey TT, Ashford N, Afrin LB. Mast cell activation may explain many cases of chemical intolerance. Environ Sci Eur. 33,129 (2021).
Palmer RF, Walker T, Perales RB, Rincon R, Jaén CR, Miller CS. Disease comorbidities associated with chemical intolerance. Environmental Disease. (2021) Oct 1;6(4):134.
Masri S, Miller CS, Palmer RF, Ashford. N. Toxicant-induced loss of tolerance for chemicals, foods, and drugs: assessing patterns of exposure behind a global phenomenon. Environ Sci Eur 33, 65 (2021).
2020
Palmer RF, Jaén CR, Perales RB, Rincon R, Forster JN, Miller CS. Three questions for identifying chemically intolerant individuals in clinical and epidemiological populations: The Brief Environmental Exposure and Sensitivity Inventory (BREESI). PLoS One. (2020) Sep 16;15(9):e0238296.
Publications
Chemical Intolerance in Primary Care Settings: Prevalence, Comorbidity and Outcomes
Katerndahl, DA, Miller CS. Ann Fam Med. 2012; 10(4):357 – 65.
The Compelling Anomaly of Chemical Intolerance
Miller CS. Ann NY Acad Sci. 2001; 933:1-23
Miller CS. Toxicol Ind Health. 1999; 15 (3-4): 284-94.
Toxicant-Induced Loss of Tolerance–an Emerging Theory of Disease?
Miller CS. Environ Health Perspect. 1997;105 Suppl 2:445-53.
Empirical Approaches for the Investigation of Toxicant-Induced Loss of Tolerance.
Miller CS, Ashford NA, Doty R, Lamielle M, Otto D, Rahill A, Wallace L. Envrion Health Perspect. 1997; 105 Suppl 2:515-19.
Chemical Sensitivity: Symptom, Syndrome or Mechanism for Disease?
Miller CS. Toxicology. 1996; 111:69-86.
Other Publications on Chemical Intolerance
Heilbrun LP, Palmer RF, Jaen CR, Svoboda MD, Perkins J, Miller CS. Maternal Chemical and Drug Intolerances: Potential Risk Factors for Autism and Attention Deficit Hyperactivity Disorder (ADHD). J Am Board Fam Med. 2015;28(4):461-70.
Toxicant-Induced Loss of Tolerance. Addiction.
Miller CS. Toxicant-induced loss of tolerance. Addiction. 2001;96(1):115-37.
Self-reported Sensitivity to Chemical Exposures in Five Clinical Populations and Healthy Controls
Nawab SS, Miller CS, Dale JK, Greenberg BD, Friedman TC, Straus SE, Chrousos GP, Rosenthal NE. Psychiatry Res. 2000; 95(1):67-74.
Exacerbation of Chemical Sensitivity: a Case Study
Miller CS, Gammage RB, Jankovic JT. Exacerbation of chemical sensitivity: a case study. Toxicol Ind Health. 1999;15(3-4):398-402.
Miller CS, Prihoda TJ. A controlled comparison of symptoms and chemical intolerances reported by Gulf War veterans, implant recipients and persons with multiple chemical sensitivity. Toxicol Ind Health. 1999;15(3-4):386-97.
Miller CS, Prihoda. Toxicol Ind Health. 1999;15 (3-4): 370-85.
